Extended intravenous DMT sessions pushed a first human volunteer through sustained altered states and raised questions about tolerance, immersion, and psychedelic research design

Extended intravenous DMT administration put a human volunteer into a prolonged psychedelic state for about two hours, far beyond the brief peak typical of smoked or injected DMT. The experience centered on what sustained exposure can reveal about consciousness, subjective adaptation, and whether tolerance emerges during a single continuous session. Continuous dosing appears to have made the state more navigable over time while preserving its intensity, suggesting that duration changes the character of DMT immersion rather than simply stretching a short trip. That setup matters for research because it can give investigators a longer window to study phenomenology, brain activity, communication, and therapeutic possibilities under controlled conditions. Safety and study design sit at the center of the discussion. Prolonged infusion raises practical questions about monitoring, participant burden, and how to distinguish novelty, acclimatization, and dose effects when a fast acting compound is held at psychedelic levels for an extended period.